Ligand profile
ZINC100937907
Virtual-screening candidate from ZINC.
Bound to: KP13_03545 — Cysteine synthase B
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC100937907- UniProt (similar protein)
P9WP55- Tanimoto
- 0.790
- Target protein
- KP13_03545
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 116.5
- −1 ≤ LogP ≤ 5 4.90
- MW ≤ 500 Da 488.5
- LogP ≤ 5 4.90
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 6
- Rotatable bonds ≤ 10 7
- TPSA ≤ 140 Ų 116.5
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CN1C(=O)/C(=C/c2ccccc2OCc2ccc(C(=O)O)cc2)S/C1=N/c1cccc(C(=O)O)c1CN1C(=O)/C(=C/c2ccccc2OCc2ccc(C(=O)O)cc2)S/C1=N/c1cccc(C(=O)O)c1
InChI=1S/C26H20N2O6S/c1-28-23(29)22(35-26(28)27-20-7-4-6-19(13-20)25(32)33)14-18-5-2-3-8-21(18)34-15-16-9-11-17(12-10-16)24(30)31/h2-14H,15H2,1H3,(H,30,31)(H,32,33)/b22-14-,27-26+InChI=1S/C26H20N2O6S/c1-28-23(29)22(35-26(28)27-20-7-4-6-19(13-20)25(32)33)14-18-5-2-3-8-21(18)34-15-16-9-11-17(12-10-16)24(30)31/h2-14H,15H2,1H3,(H,30,31)(H,32,33)/b22-14-,27-26+
XPVWDZSLPUZSIS-ZPHFMMIUSA-NXPVWDZSLPUZSIS-ZPHFMMIUSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- AWH
- Homolog
- P9WP55
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC100937907 →
- ZINC ZINC20 ZINC100937907 →
- UniProt UniProt P9WP55 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC100937907”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_03545.
PDB 8
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 15
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).